This DOLF study will investigate the safety and effectiveness of IDA treatment in persons
with onchocerciasis when it is administered after pre-treatment with ivermectin to clear or
greatly reduce microfilariae from the skin and eyes.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Collaborators:
Case Western Reserve University University of Health and Allied Sciences